Quantitative Developer at JPMorgan Chase & Co.
Greater New York City Area
• Worked with the Portfolio Manager in conducting quantitative analysis of big financial data-set, building trading models with VBA and R, Market and Risk analysis • Created auto-refresh Advanced Trading Model to value thousands of stocks in one time and give trading advice to clients in a more direct and efficient way • Built Adjusted Relative Strength... • Worked with the Portfolio Manager in conducting quantitative analysis of big financial data-set, building trading models with VBA and R, Market and Risk analysis • Created auto-refresh Advanced Trading Model to value thousands of stocks in one time and give trading advice to clients in a more direct and efficient way • Built Adjusted Relative Strength Index Model to calculate different estimations of stocks, forecast turning-point stock price and provide recession signals, which makes a powerful way to predict the performance of stocks and monitor the market
📖 Summary
Expecting to achieve M.S in Statistics at Rice University in December 2015. Solid background in quantitative analysis, programming, market and risk analysis Actively seeking full-time opportunities in data analysis, quantitative research and consulting Feel free to contact me at [email protected] @ • Worked with the Portfolio Manager in conducting quantitative analysis of big financial data-set, building trading models with VBA and R, Market and Risk analysis • Created auto-refresh Advanced Trading Model to value thousands of stocks in one time and give trading advice to clients in a more direct and efficient way • Built Adjusted Relative Strength Index Model to calculate different estimations of stocks, forecast turning-point stock price and provide recession signals, which makes a powerful way to predict the performance of stocks and monitor the market From July 2015 to October 2015 (4 months) Houston, Texas AreaCo-Founder of Sweatalyzer/ Market Analyst @ • Co-founded a startup developing a novel alcohol diagnostic device, supported by OwlSpark Accelerator, a Rice entrepreneurship program (top 20% approved) • Created businesses plan with data-driven research, managed and interpreted the results of large-scale client database analyses, built models to test hypothetical target market segment • Evaluated productivity and profitability of new product and greatly supported market promotion From May 2013 to August 2013 (4 months) Student Researcher (Data Analysis) @ Developed a medical device for disease detection in a ten-person team Collected valid images by geometrically mapping pixels with settled biomarkers, used regression model to fit collected data of image intensity and disease concentration, employed fitted curve to predict unknown disease concentration From January 2013 to May 2013 (5 months) Master’s Degree, Statistics, 3.8 @ Rice University From 2014 to 2015 Master's degree, Bioengineering and Biomedical Engineering @ Rice University From 2012 to 2014 Bachelor's degree, Bioengineering and Biomedical Engineering, 3.6 @ Beihang University From 2008 to 2012 Tuo Li is skilled in: Matlab, Cell Culture, Biotechnology, Biomedical Engineering, Biochemistry, Molecular Biology, Microsoft Excel, Microscopy, Microsoft Office, HPLC, PCR, PowerPoint, Gel Electrophoresis, Microsoft Word, Solidworks
What company does Tuo Li work for?
Tuo Li works for Morgan Stanley
What is Tuo Li's role at Morgan Stanley?
Tuo Li is Internship
What industry does Tuo Li work in?
Tuo Li works in the Investment Banking industry.
Who are Tuo Li's colleagues?
Tuo Li's colleagues are Jasmine Chabra, Vipul Patel, Taylor Lehman, Brian Dean, Elie Mekanna, Varun Bhatia, Tyrone Saunders, Tara Miskiewicz, Kyle Moses, and Monica Ting
Extraversion (E), Intuition (N), Feeling (F), Judging (J)
0 year(s), 4 month(s)
Unlikely
Likely
There's 100% chance that Tuo Li is seeking for new opportunities
Enjoy unlimited access and discover candidates outside of LinkedIn
One billion email addresses and counting
Everything you need to engage with more prospects.
ContactOut is used by
76% of Fortune 500 companies